Mimetas raises $20.5M in series B

Organ-on-a-chip company Mimetas B.V. (Leiden, the Netherlands) raised $20.5 million on April 11 in a series B round led by new investor European Life Sciences Growth Fund. New investors Aglaia Oncology Fund II, Korys, Cathay Venture and InnovationQuarter also participated, as did existing investor Oost NL...